Technical, economic, and clinical challenges to the development of new biomaterials-based vaccines
Thesis (M. Eng.)--Massachusetts Institute of Technology, Dept. of Materials Science and Engineering, 2005.
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | eng |
| Published: |
Massachusetts Institute of Technology
2006
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/1721.1/33623 |
| _version_ | 1811076333025886208 |
|---|---|
| author | Huffman, Kathleen Renee |
| author2 | Darrell J. Irvine. |
| author_facet | Darrell J. Irvine. Huffman, Kathleen Renee |
| author_sort | Huffman, Kathleen Renee |
| collection | MIT |
| description | Thesis (M. Eng.)--Massachusetts Institute of Technology, Dept. of Materials Science and Engineering, 2005. |
| first_indexed | 2024-09-23T10:19:43Z |
| format | Thesis |
| id | mit-1721.1/33623 |
| institution | Massachusetts Institute of Technology |
| language | eng |
| last_indexed | 2024-09-23T10:19:43Z |
| publishDate | 2006 |
| publisher | Massachusetts Institute of Technology |
| record_format | dspace |
| spelling | mit-1721.1/336232019-04-11T10:29:37Z Technical, economic, and clinical challenges to the development of new biomaterials-based vaccines Huffman, Kathleen Renee Darrell J. Irvine. Massachusetts Institute of Technology. Dept. of Materials Science and Engineering. Massachusetts Institute of Technology. Dept. of Materials Science and Engineering. Materials Science and Engineering. Thesis (M. Eng.)--Massachusetts Institute of Technology, Dept. of Materials Science and Engineering, 2005. Includes bibliographical references (leaves 81-87). Research into novel vaccine methods is becoming increasingly important for the potential treatment of widespread diseases such as cancer, HIV, and malaria. Members of the Irvine laboratory have developed a hydrogel and particle-based injectable vaccine with the potential to treat such diseases. The vaccine aims to elicit a tailored immune response to a particular type of disease so as to destroy infected or cells in the body and/or develop immunological memory for future protection against the disease. The purpose of this paper is to analyze the feasibility of getting such a biomaterials-based novel vaccination method to the market. Topics such as application potential, efficacy, modes of delivery, storage, patent ability, and costs for producing the vaccine are explored. Finally, a suggested business strategy is outlined, through which value can be successfully obtained from the novel vaccine. by Kathleen Renee Huffman. M.Eng. 2006-07-31T15:17:56Z 2006-07-31T15:17:56Z 2005 2005 Thesis http://hdl.handle.net/1721.1/33623 64391658 eng M.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission. http://dspace.mit.edu/handle/1721.1/7582 87 leaves 6229284 bytes 6233211 bytes application/pdf application/pdf application/pdf Massachusetts Institute of Technology |
| spellingShingle | Materials Science and Engineering. Huffman, Kathleen Renee Technical, economic, and clinical challenges to the development of new biomaterials-based vaccines |
| title | Technical, economic, and clinical challenges to the development of new biomaterials-based vaccines |
| title_full | Technical, economic, and clinical challenges to the development of new biomaterials-based vaccines |
| title_fullStr | Technical, economic, and clinical challenges to the development of new biomaterials-based vaccines |
| title_full_unstemmed | Technical, economic, and clinical challenges to the development of new biomaterials-based vaccines |
| title_short | Technical, economic, and clinical challenges to the development of new biomaterials-based vaccines |
| title_sort | technical economic and clinical challenges to the development of new biomaterials based vaccines |
| topic | Materials Science and Engineering. |
| url | http://hdl.handle.net/1721.1/33623 |
| work_keys_str_mv | AT huffmankathleenrenee technicaleconomicandclinicalchallengestothedevelopmentofnewbiomaterialsbasedvaccines |